Min Wang has been appointed chief legal and administrative officer of Cambridge, MA-based BlueRock Therapeutics. Wang was most recently general counsel and corporate secretary of Agios Pharmaceuticals (NASDAQ: [[ticker:AGIO]]). Her experience also includes posts at Genentech and Merck (NYSE: [[ticker:MRK]]). BlueRock, which develops regenerative medicines for tough-to-treat diseases, launched in late 2016 backed by $225 million in funding.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
